Discovering Therapy Options for Hard-to-Treat and Rare Cancers with Sanjeev Luther, President & CEO of Rafael Pharmaceuticals
Cancer is a prevalent condition that impacts not just the patients but also families, employers, and society. Without the right management and medication it can lead to financial loss, reduced quality of life, and even death.
In today’s episode, we are honored and thrilled to have Sanjeev Luther, CEO and President of Rafael Pharmaceuticals. Sanjeev discusses his company’s mission to develop highly effective anti-cancer agents to improve the quality of life of patients with g AML, Burkitts & pancreatic cancer. He shares his insights on innovation, collaborations, AI, challenges in the pharma space, fundamental shifts among regulation due to COVID, and many more. This is a great conversation on oncology in pharma so don’t miss it!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
